Benign prostatic hypertrophy research hub

SERENDIPITY: phase III multicentric randomized study assessing the reduction of chronic prostate inflammation with Permixon®

This clinical trial looks at whether a medicine called Permixon can help men with an enlarged prostate. Researchers want to see if calming prostate inflammation lowers the need for a repeat prostate biopsy within 12 months, while also checking urinary symptoms and overall prostate health.